benazepril hydrochloride and hydrochlorothiazide

Generic: benazepril hydrochloride and hydrochlorothiazide

Labeler: Apotex Corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name benazepril hydrochloride and hydrochlorothiazide
Generic Name benazepril hydrochloride and hydrochlorothiazide
Labeler Apotex Corp.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

BENAZEPRIL HYDROCHLORIDE 5 mg/1, HYDROCHLOROTHIAZIDE 6.25 mg/1

Identifiers & Regulatory

Product NDC 60505-0261
Product ID 60505-0261_4bc1d8b0-abd1-a719-49bf-3278164bc3ac
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078794
Marketing Start 2014-08-21
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605050261
Hyphenated Format 60505-0261

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)
Generic Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)
Application Number ANDA078794 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 6.25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (60505-0261-1)
source: ndc

Packages (1)

60505-0261-1 100 TABLET in 1 BOTTLE (60505-0261-1)

Ingredients (2)

BENAZEPRIL HYDROCHLORIDE (5 mg/1) HYDROCHLOROTHIAZIDE (6.25 mg/1)

Linked Drug Pages (1)

benazepril hydrochloride and hydrochlorothiazide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4bc1d8b0-abd1-a719-49bf-3278164bc3ac", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["N1SN99T69T", "0J48LPH2TH"], "rxcui": ["898362", "898367", "898372", "898378"], "spl_set_id": ["e7222f81-3e6b-dfe1-379a-83ca350f91a9"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60505-0261-1)", "package_ndc": "60505-0261-1", "marketing_end_date": "20260228", "marketing_start_date": "20140821"}], "brand_name": "benazepril hydrochloride and hydrochlorothiazide", "product_id": "60505-0261_4bc1d8b0-abd1-a719-49bf-3278164bc3ac", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "60505-0261", "generic_name": "benazepril hydrochloride and hydrochlorothiazide", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "benazepril hydrochloride and hydrochlorothiazide", "active_ingredients": [{"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "6.25 mg/1"}], "application_number": "ANDA078794", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20140821"}